home.social

#cannabisresearch — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #cannabisresearch, aggregated by home.social.

  1. US DITCHES DRUG SCHEDULE FOR WEED

    The US government has moved cannabis from Schedule I to Schedule III. This change makes it easier to research weed's medical uses. It affects patients and researchers.

    #cannabisresearch, #drugpolicy, #medicalmarijuana, #USnews, #ScheduleIII

    newsletter.tf/us-moves-weed-sc

  2. The US government has moved cannabis from Schedule I to Schedule III, a lower category. This is a big change from its previous classification alongside drugs like heroin.

    #cannabisresearch, #drugpolicy, #medicalmarijuana, #USnews, #ScheduleIII
    newsletter.tf/us-moves-weed-sc

  3. [Known as the “father of #cannabisresearch,” #RaphaelMechoulam, PhD, will go down in history as one of those scientists who should have won the Nobel Prize—but didn’t ... His pioneering spirit and scientific achievements have benefited millions of patients and helped to ignite the burgeoning field of #cannabismedicine as we know it today.] endocannabinoidmedicine.com/fe

    👍 📡 🌐 youtu.be/5BGS5JzLlvs
    #WEEDMoB #Hanfgeschichten #hanf #hemp #marijuana #Cannabis

  4. 🍁🔬 Hidden treasures in cannabis waste! Scientists discover rare flavoalkaloids in leaves, with potential anti-inflammatory & antioxidant benefits. A new medical frontier from discarded plant material! Read more: thedebrief.org/cannabis-waste-

    @goodnews

    #GoodNews #CannabisResearch #MedicalDiscovery #PlantPower #ScienceWin

  5. @SteveThompson

    Nice skeptic article as any true science should be. Anything that links the 2011 Russo paper "Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects" is to be celebrated. Here is the link again in case somebody missed it.

    bpspubs.onlinelibrary.wiley.co

    Russo's paper has been cited 1,161 times and it deals with exogenous cannabinoids and terpenes synergy, not just endogenous o made inside our body, as did the original 1998 Mechoulam research.

    Indeed, due to obsolete prohibitionism and sad profit-comes-first mentality, the current cannabis and hemp markets are a wild west of fake adultered product and unproven claims.

    Yet since 2011 hundreds of studies have confirmed the entourage effect. Here is a small and incomplete collection of full spectrum extract papers 2004-2023.

    cvresearch.info/full-spectrum-

    OPs article calls for more standarized extract testing, even though Big Pharmas really prefers patentable, cheap to make, single molecule, symptom masking drugs. Good luck with that.

    I agree with the article bottomline: governments should step up to the research task instead of trusting this critical matter to profit-driven corporations. Mixed isolate cannabis pharmaceuticals have been in the market for over a decade and proven their capabilities and limitations.

    That is the case of Sativex, a 700 US$ 1:1 (thc:cbd) oral spray that controls some symptoms of MS yet fails to work for other conditions. Three separate studies ( Israeli, Brazilian and American) have since proven that full flower artisanal extracts are up to 6x more effective than expensive isolate preparations like Sativex
    sensiseeds-com.translate.goog/

    #Cannabis #cannabismedicinal #thc #thca #cbd #cbda #entourageeffect
    #cannabislegal #Cannabisgesetz
    #cannabislegalisierung #ganja
    #maconha #weed #cannabisculture
    #cannabisresearch #chronicillness
    #ptsd #arthritis #stress #depression
    #multiplesclerosis #ImmuneSystem

  6. @SteveThompson

    Nice skeptic article as any true science should be. Anything that links the 2011 Russo paper "Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects" is to be celebrated. Here is the link again in case somebody missed it.

    bpspubs.onlinelibrary.wiley.co

    Russo's paper has been cited 1,161 times and it deals with exogenous cannabinoids and terpenes synergy, not just endogenous o made inside our body, as did the original 1998 Mechoulam research.

    Indeed, due to obsolete prohibitionism and sad profit-comes-first mentality, the current cannabis and hemp markets are a wild west of fake adultered product and unproven claims.

    Yet since 2011 hundreds of studies have confirmed the entourage effect. Here is a small and incomplete collection of full spectrum extract papers 2004-2023.

    cvresearch.info/full-spectrum-

    OPs article calls for more standarized extract testing, even though Big Pharmas really prefers patentable, cheap to make, single molecule, symptom masking drugs. Good luck with that.

    I agree with the article bottomline: governments should step up to the research task instead of trusting this critical matter to profit-driven corporations. Mixed isolate cannabis pharmaceuticals have been in the market for over a decade and proven their capabilities and limitations.

    That is the case of Sativex, a 700 US$ 1:1 (thc:cbd) oral spray that controls some symptoms of MS yet fails to work for other conditions. Three separate studies ( Israeli, Brazilian and American) have since proven that full flower artisanal extracts are up to 6x more effective than expensive isolate preparations like Sativex
    sensiseeds-com.translate.goog/

    #Cannabis #cannabismedicinal #thc #thca #cbd #cbda #entourageeffect
    #cannabislegal #Cannabisgesetz
    #cannabislegalisierung #ganja
    #maconha #weed #cannabisculture
    #cannabisresearch #chronicillness
    #ptsd #arthritis #stress #depression
    #multiplesclerosis #ImmuneSystem

  7. @SteveThompson

    Nice skeptic article as any true science should be. Anything that links the 2011 Russo paper "Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects" is to be celebrated. Here is the link again in case somebody missed it.

    bpspubs.onlinelibrary.wiley.co

    Russo's paper has been cited 1,161 times and it deals with exogenous cannabinoids and terpenes synergy, not just endogenous o made inside our body, as did the original 1998 Mechoulam research.

    Indeed, due to obsolete prohibitionism and sad profit-comes-first mentality, the current cannabis and hemp markets are a wild west of fake adultered product and unproven claims.

    Yet since 2011 hundreds of studies have confirmed the entourage effect. Here is a small and incomplete collection of full spectrum extract papers 2004-2023.

    cvresearch.info/full-spectrum-

    OPs article calls for more standarized extract testing, even though Big Pharmas really prefers patentable, cheap to make, single molecule, symptom masking drugs. Good luck with that.

    I agree with the article bottomline: governments should step up to the research task instead of trusting this critical matter to profit-driven corporations. Mixed isolate cannabis pharmaceuticals have been in the market for over a decade and proven their capabilities and limitations.

    That is the case of Sativex, a 700 US$ 1:1 (thc:cbd) oral spray that controls some symptoms of MS yet fails to work for other conditions. Three separate studies ( Israeli, Brazilian and American) have since proven that full flower artisanal extracts are up to 6x more effective than expensive isolate preparations like Sativex
    sensiseeds-com.translate.goog/

    #Cannabis #cannabismedicinal #thc #thca #cbd #cbda #entourageeffect
    #cannabislegal #Cannabisgesetz
    #cannabislegalisierung #ganja
    #maconha #weed #cannabisculture
    #cannabisresearch #chronicillness
    #ptsd #arthritis #stress #depression
    #multiplesclerosis #ImmuneSystem

  8. Zürcher Anwalt sucht 5000 Kiffer:innen für Cannabis - Pilotversuch

    «Das Verbot von #Cannabis ist auf unsere Politik zurückzuführen, nicht auf wissenschaftliche Erkenntnisse.» Paul-Lukas Good, Jurist und Präsident des Vereins «#CannabisResearch»

    Schweizer Gras für Schweizer Kiffer:innen: Rechtsanwalt Paul Good sieht viel Potential in der Züchtung von Schweizer Biohanf.

    Jedes «kiffende Grosi» willkommen
    tsri.ch/zh/zuercher-anwalt-goo

    #CannabisLegalisierung #Schweiz #Biohanf #Studie #Weedmob

  9. Glenn Healy says NHL Alumni Association ‘all-in’ on cannabis research

    NHL Alumni Association Teams Up With Canopy Growth to Research Concussions and Cannabinoids

    New study led by NEEKA Health Canada will test if CBD-based therapies can reduce the severity of post-concussion brain disorders in former NHL players

    prnewswire.com/news-releases/n

    sportsnet.ca/hockey/nhl/mariju

    #NHL #ConcussionAwareness #concussion #cannabis #TBI #hockey #GoBowls #GlennHealy #CannabisResearch #NaturesPharmaceutical

  10. Glenn Healy says NHL Alumni Association ‘all-in’ on cannabis research

    NHL Alumni Association Teams Up With Canopy Growth to Research Concussions and Cannabinoids

    New study led by NEEKA Health Canada will test if CBD-based therapies can reduce the severity of post-concussion brain disorders in former NHL players

    prnewswire.com/news-releases/n

    #NHL #ConcussionAwareness #concussion #cannabis #TBI #hockey #GoBowls #GlennHealy #CannabisResearch #NaturesPharmaceutical

    @hockey @bostonbruinsgameday

  11. “Cannabis,  Alzheimers, TBI and Invisible Disability"

    Click here 🧠 to expand.

    Cannabis can still be a controversial topic. The medical benefits for those with physical and invisible disabilities are no secret. People with Invisible disabilities, such as brain injury and PTSD, can be afforded great relief from symptoms by the flower.

    Israeli Dr. Raphael Mechoulam, is a well known cannabis research pioneer who has been studying the plant for decades. Read about some of his work in the link below.

    Other Research indicates that individuals living with Alzheimers and Dementia may also benefit with less risk and damaging effects than other drugs currently used. 

    Findings from another Israeli Researcher, Dedi Meiri, argue that there may be benefits to these individuals as well.

    "There is a large and growing body of anecdotal accounts of the efficacy of cannabis for treating the symptoms of Alzheimer’s disease and dementia. The shortcomings ... life-threatening dangers...with... frequently prescribed pharmaceutical treatments... makes cannabis a particularly compelling option – especially considering its solid safety profile."

    Even more research from the National Library of Medicine (PubMed.gov), speaks about the neuroprotectant antioxidant qualities of the herb. The PubMed link below contains several links to other studies on cannabis and it’s benefits for people with disabilities.

    The human body is said to have CBD receptors "built" in. I am neither condoning, nor condemning the use of “Natures Pharmaceutical"; nor am I suggesting it's use. I am merely presenting medical findings.

    According to laws in many places amidst these findings, the jury is still out on the subject.

    MedGov:
    pubmed.ncbi.nlm.nih.gov/108635

    Dr. Mechoulam:
    nbcnews.com/tech/innovation/ca

    Alzheimers:
    forbes.com/sites/abbierosner/2

    NHL alum study on concussion and Cannabis:
    prnewswire.com/news-releases/n

    On regeneration and prevention ofAlzheimers:
    cryptosavvy.com/2018/09/cannab

    On reversing aging:
    dailyhealthpost.com/cannabis-r

    Image courtesy of:
    merryjane.com/culture/heres-ho

    #RaphaelMechoulam #CannabisResearch #Pain #Relief #neuroprotectant #antioxidant #InvisibleDisability #disability #MentalHealth #anxiety #CBD #CbdReceptors #THC #TBI #alzheimers #PTSD #BrainInjury #SpineInjury #cannabis #flower #herb #Truth #KanehBosem #biblical #pot #TheDevilsParsley #ganja #NaturesPharmaceutical #InvisibleDisabilityRights
    #HashtagsNobodyWillEverSearch

    Originally posted Dec 04, 2022, 02:15 by OutOfExile_IDR

  12. CW: Cannabis Alzheimers TBI Invis Disability

    1of2
    Cannabis can still be a controversial topic. The medical benefits for those with physical and invisible disabilities are no secret. People with Invisible disabilities such as #braininjury and #PTSD, can be afforded great relief from symptoms by the #flower.

    Israeli Dr. Raphael Mechoulam is a well known #cannabis research pioneer who has been studying the plant for decades. Read about some of his work in the link below.

    Other Research indicates that individuals living with Alzheimers and Dementia may also benefit with less risk than other drugs currently used.

    Findings from another Israeli Researcher, Dedi Meiri, argue that there may be benefits to these individuals as well.

    "There is a large and growing body of anecdotal accounts of the efficacy of cannabis for treating the symptoms of Alzheimer’s disease and dementia. The shortcomings ... life-threatening dangers...with... frequently prescribed pharmaceutical treatments... makes cannabis a particularly compelling option – especially considering its solid safety profile."

    Even more research from the National Library of Medicine (PubMed.gov), speaks about the #neuroprotectant #antioxidant qualities of the #herb. The link below contains several links to others studies on cannabis and the relief for with people with #disabilities.

    The human body is said to have CBD receptors "built" in. I am neither condoning, nor condemning the use of #NaturesPharmaceutical; nor am I suggesting it's use. I am merely presenting medical findings.

    The little graphic I created below a few years ago, also is not an indication of support or use. According to laws in many places amidst these findings, the jury is still out.😉

    MedGov:
    pubmed.ncbi.nlm.nih.gov/108635

    Dr. Mechoulam:
    nbcnews.com/tech/innovation/ca

    Alzheimers:
    forbes.com/sites/abbierosner/2

    #RaphaelMechoulam #CannabisResearch #Pain Relief #InvisibleDisability #disability #MentalHealth #anxiety #CBD #CbdReceptors #THC

    Main:
    @[email protected]